These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Biodistribution and in vivo kinetics of iodine-131 lipiodol infused via the hepatic artery of patients with hepatic cancer. Nakajo M; Kobayashi H; Shimabukuro K; Shirono K; Sakata H; Taguchi M; Uchiyama N; Sonoda T; Shinohara S J Nucl Med; 1988 Jun; 29(6):1066-77. PubMed ID: 2836573 [TBL] [Abstract][Full Text] [Related]
6. Chemoembolization of hepatocellular carcinomas. A study of the biodistribution and pharmacokinetics of doxorubicin. Raoul JL; Heresbach D; Bretagne JF; Ferrer DB; Duvauferrier R; Bourguet P; Messner M; Gosselin M Cancer; 1992 Aug; 70(3):585-90. PubMed ID: 1320447 [TBL] [Abstract][Full Text] [Related]
7. Preliminary results of the Phase 1 Lip-Re I clinical trial: biodistribution and dosimetry assessments in hepatocellular carcinoma patients treated with Delaunay K; Edeline J; Rolland Y; Lepareur N; Laffont S; Palard X; Bouvry C; Le Sourd S; Pracht M; Ardisson V; Noiret N; Bellissant É; Garin E Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1506-1517. PubMed ID: 30715571 [TBL] [Abstract][Full Text] [Related]
8. Development and biodistribution of 188Re-SSS lipiodol following injection into the hepatic artery of healthy pigs. Garin E; Noiret N; Malbert C; Lepareur N; Roucoux A; Caulet-Maugendre S; Moisan A; Lecloirec J; Herry JY; Bourguet P Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):542-6. PubMed ID: 14691613 [TBL] [Abstract][Full Text] [Related]
9. Biodistribution of Lipiodol following hepatic arterial injection. Hind RE; Loizidou M; Perring S; Fleming J; Batty V; Birch S; Taylor I Br J Surg; 1992 Sep; 79(9):952-4. PubMed ID: 1330198 [TBL] [Abstract][Full Text] [Related]
10. Value of hepatic arterial phase CT versus lipiodol ultrafluid CT in the detection of hepatocellular carcinoma. Colagrande S; Fargnoli R; Dal Pozzo F; Bindi A; Rega L; Villari N J Comput Assist Tomogr; 2000; 24(6):878-83. PubMed ID: 11105704 [TBL] [Abstract][Full Text] [Related]
11. Limitations of hyperselective intraarterial injections for the treatment of hepatocellular carcinoma. Raoul JL; Bretagne JF; Bourguet P; Duvauferrier R Invest Radiol; 1996 May; 31(5):305-7. PubMed ID: 8724131 [TBL] [Abstract][Full Text] [Related]
13. Estimation of the kinetics of iodized oil injected into the feeding artery of hepatocellular carcinoma using dynamic computed tomography. Inoue H; Miyazono N; Miyake S; Nishida H; Kanetsuki I; Hori A; Mukai H; Ueno K; Nakajo M Radiat Med; 1994; 12(2):53-8. PubMed ID: 8079003 [TBL] [Abstract][Full Text] [Related]
14. 131I thyroid uptake in patients treated with 131I-Lipiodol for hepatocellular carcinoma. Toubeau M; Touzery C; Berriolo-Riedinger A; Cochet A; Brunotte F; Bedenne L; Cercueil JP; Krause D Eur J Nucl Med; 2001 May; 28(5):669-70. PubMed ID: 11383874 [No Abstract] [Full Text] [Related]
15. Selective and persistent deposition and gradual drainage of iodized oil, Lipiodol in the hepatocellular carcinoma after injection into the feeding hepatic artery. Okayasu I; Hatakeyama S; Yoshida T; Yoshimatsu S; Tsuruta K; Miyamoto H; Kimula Y Am J Clin Pathol; 1988 Nov; 90(5):536-44. PubMed ID: 2459957 [TBL] [Abstract][Full Text] [Related]
16. [The CT scan coupled to the injection of lipiodol into the hepatic artery. Preliminary trial]. Bruneton JN; Grimaldi C; Kerboul P; Rampal P; Namer M; Bourry J; Delmont J Ann Gastroenterol Hepatol (Paris); 1985 Dec; 21(6):409-12. PubMed ID: 3006580 [TBL] [Abstract][Full Text] [Related]
17. Distribution of Lipiodol in hepatocellular carcinoma. Park C; Choi SI; Kim H; Yoo HS; Lee YB Liver; 1990 Apr; 10(2):72-8. PubMed ID: 2161978 [TBL] [Abstract][Full Text] [Related]
18. Biodistribution of lipiodol following hepatic arterial injection. Hind RE; Loizidou M; Fleming J; Batty V; Birch S; Taylor I Eur J Surg Oncol; 1992 Apr; 18(2):162-7. PubMed ID: 1316290 [TBL] [Abstract][Full Text] [Related]
19. Usefulness of hepatic artery injection of iodized oil and 131I-labeled iodized oil before the therapeutic decision in hepatocellular carcinoma. Raoul JL; Duvauferrier R; Bretagne JF; Bourguet P; Heresbach D; Siproudhis L; Gosselin M Scand J Gastroenterol; 1993 Mar; 28(3):217-23. PubMed ID: 7680489 [TBL] [Abstract][Full Text] [Related]
20. Nodular hepatocellular carcinoma--treatment with intraarterial injection of I-131 Lipiodol. Yoo HS; Suh JH; Lee JT; Kim KW; Kim DI; Kim BS; Choi HJ; Lee KS J Korean Med Sci; 1990 Jun; 5(2):75-83. PubMed ID: 2177607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]